June 28, 2004 — Pharmanex scientists recently announced that they have made significant advancements in several nutritional health categories. Independent scientific associations and journals recently recognized these scientific achievements by inviting Pharmanex scientists to present their findings and by publishing its research. Leading research organizations have also independently tested Pharmanex products in their studies and found positive results.

"The Pharmanex research and development team is keeping us at the forefront in scientific advancement in the nutritional supplement category," said Truman Hunt, CEO and president of Nu Skin Enterprises, parent company to Pharmanex. "We are pleased to be recognized for our scientific achievement in the nutritional supplement industry. Our commitment to scientifically measuring the safety and efficacy of our nutritional products is setting the standard in the industry and helping people to live better, longer."

During the first part of 2004, Pharmanex have been recognized for its scientific efforts in antioxidant protection, aerobic performance and endurance and liver protection. Independent researchers also conducted a study on the Pharmanex product ReishiMax® in relation to breast cell health. To read more about these specific efforts, visit http://www.nuskinenterprises.com/corp/media/press_releases/06-15-04-1.shtml?linkID=4&oldLinkID=4.

According to Joseph Chang, Ph.D., president of Pharmanex, "The results of these studies validate the efficacy of our products. With over 75 full-time scientists on staff and advisory relationships with leading researchers and universities, Pharmanex continues to build a body of knowledge in key nutritional and health categories."